BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 12, Issue 9
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (1487)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-4) series.
Item 
Count 
PDF30
HTML759
Figures (1-4)78
 Sum=867
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse136
Download270
 Sum=406
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse36
Download117
 Sum=153
Mar 26, 2024 (publication date) through Jul 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Xu X, Jiang JW, Lu BY, Li XX. Upadacitinib for refractory ulcerative colitis with primary nonresponse to infliximab and vedolizumab: A case report. World J Clin Cases 2024; 12(9): 1685-1690 [PMID: 38576732 DOI: 10.12998/wjcc.v12.i9.1685]
URL: https://www.wjgnet.com/2307-8960/full/v12/i9/1685.htm
Number Citing Articles
1
Jonathan Soldera. Navigating treatment resistance: Janus kinase inhibitors for ulcerative colitis. World Journal of Clinical Cases 2024; 12(24): 5468-5472 doi: 10.12998/wjcc.v12.i24.5468
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345